High-dose interferon versus GM2 vaccine in high-risk malignant melanoma.
Wilson
K
K
D019496:Cancer Vaccines / Q000627:therapeutic use; D003627:Data Interpretation, Statistical; D049289:G(M2) Activator Protein; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy / Q000401:mortality*; D011506:Proteins / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000401:mortality*; D016019:Survival Analysis
D019496:Cancer Vaccines; D049289:G(M2) Activator Protein; D011506:Proteins; D007372:Interferons